Literature DB >> 23960026

Muscle mass predicts outcomes following liver transplantation.

Andrea DiMartini1, Ruy J Cruz, Mary Amanda Dew, Larissa Myaskovsky, Bret Goodpaster, Kristen Fox, Kevin H Kim, Paulo Fontes.   

Abstract

For patients with end-stage liver disease, commonly used indices of nutritional status (ie, body weight and body mass index) are often inflated because of fluid overload (ie, ascites and peripheral edema), and this results in an underdiagnosis of malnutrition. Because muscle is the largest protein reservoir in the body, an estimate of the muscle mass may be a more reliable and valid estimate of nutritional status. Therefore, we used pretransplant computed tomography data for 338 liver transplantation (LT) candidates to identify muscle and fat mass on the basis of a specific abdominal transverse section commonly used in body composition analyses, and we investigated the contribution of this measure to specific post-LT outcomes. We found that the majority of our patients (68%) could be defined as cachectic. For men, muscle mass predicted many important posttransplant outcomes, including intensive care unit (ICU) stay, total length of stay (LOS), and days of intubation. Muscle mass was a significant predictor of survival and also predicted disposition to home versus another facility. For women, muscle mass predicted ICU stay, total LOS, and days of intubation, but the effect was modest. Muscle mass did not predict survival or disposition for women. In conclusion, because pretransplant muscle mass is associated with many important postoperative outcomes, we discuss these findings in the context of possible pretransplant interventions for either improving or sustaining muscle mass before surgery.
© 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23960026      PMCID: PMC4382961          DOI: 10.1002/lt.23724

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  17 in total

1.  Standardized thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients.

Authors:  S Ohkawa; M Odamaki; T Yoneyama; I Hibi; K Miyaji; H Kumagai
Journal:  Am J Clin Nutr       Date:  2000-02       Impact factor: 7.045

Review 2.  Exercise capacity and muscle strength in patients with cirrhosis.

Authors:  Jacqueline C Jones; Jeff S Coombes; Graeme A Macdonald
Journal:  Liver Transpl       Date:  2012-02       Impact factor: 5.799

3.  Sarcopenia and mortality after liver transplantation.

Authors:  Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal:  J Am Coll Surg       Date:  2010-06-26       Impact factor: 6.113

4.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr.

Authors:  I Janssen; S B Heymsfield; Z M Wang; R Ross
Journal:  J Appl Physiol (1985)       Date:  2000-07

7.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

8.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

9.  Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.

Authors:  Benjamin H L Tan; Laura A Birdsell; Lisa Martin; Vickie E Baracos; Kenneth C H Fearon
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

Review 10.  Exercise limitation following transplantation.

Authors:  Trevor J Williams; Michael J McKenna
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

View more
  56 in total

1.  A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.

Authors:  Elizabeth J Carey; Jennifer C Lai; Christopher Sonnenday; Elliot B Tapper; Puneeta Tandon; Andres Duarte-Rojo; Michael A Dunn; Cynthia Tsien; Eric R Kallwitz; Vicky Ng; Srinivasan Dasarathy; Matthew Kappus; Mustafa R Bashir; Aldo J Montano-Loza
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

3.  A multicenter study to define sarcopenia in patients with end-stage liver disease.

Authors:  Elizabeth J Carey; Jennifer C Lai; Connie W Wang; Srinivasan Dasarathy; Iryna Lobach; Aldo J Montano-Loza; Michael A Dunn
Journal:  Liver Transpl       Date:  2017-05       Impact factor: 5.799

Review 4.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

5.  Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.

Authors:  Selena Z Kuo; Myra Ahmad; Michael A Dunn; Aldo J Montano-Loza; Elizabeth J Carey; Shezhang Lin; Akshata Moghe; Hui-Wei Chen; Maryam Ebadi; Jennifer C Lai
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

6.  Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.

Authors:  Michael A Dunn; Deborah A Josbeno; Amit D Tevar; Vikrant Rachakonda; Swaytha R Ganesh; Amy R Schmotzer; Elizabeth A Kallenborn; Jaideep Behari; Douglas P Landsittel; Andrea F DiMartini; Anthony Delitto
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

Review 7.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 8.  Role of Nutrition and Muscle in Cirrhosis.

Authors:  Ragesh B Thandassery; Aldo J Montano-Loza
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

Review 9.  Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?

Authors:  Guido Stirnimann; Maryam Ebadi; Puneeta Tandon; Aldo J Montano-Loza
Journal:  Curr Gastroenterol Rep       Date:  2018-09-26

10.  Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures.

Authors:  Ching-Di Chang; Jim S Wu; Jennifer Ni Mhuircheartaigh; Marry G Hochman; Edward K Rodriguez; Paul T Appleton; Colm J Mcmahon
Journal:  Skeletal Radiol       Date:  2017-12-15       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.